Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Pixelbiosciences GmbH has 1 pending office action currently under review. This action is assigned to 1 distinct examiner, YU, TIAN NMN. As the busiest examiner, YU, TIAN NMN is responsible for 1 pending office action, which constitutes the entire pending portfolio. This concentration means the immediate success of the prosecution rests with this single official. Practitioners should focus their strategy on the specific requirements and historical patterns of this examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YU, TIAN NMN | 1 | 55.6% | +19.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694073 | MEANS AND METHOD FOR FLUORESCENT IN SITU HYBRIDIZATION USING CRISPR-CAS9 VARIANTS AND A NUCLEASE | YU, TIAN NMN | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18694073 | MEANS AND METHOD FOR FLUORESCENT IN SITU HYBRIDIZATION USING CRISPR-CAS9 VARIANTS AND A NUCLEASE | YU, TIAN NMN | — | §103 | Final Rejection | — | Pending | Mar 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPixelbiosciences GmbH has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Tian Nmn Yu has the most, with 1 of Pixelbiosciences GmbH's pending office actions.